Adaptimmune Therapeutics PLC 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Adrian Rawcliffe | 6 | -115,184 |
John Lunger | 5 | -48,376 |
Bertrand William C Jr | 4 | -46,074 |
Elliot Norry | 4 | -45,822 |
Garry E Menzel | 1 | -47,702 |
Cintia Piccina | 1 | -11,890 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 165,799 | -165,799 |
最近12个月 | 0 | 221,333 | -221,333 |
最近18个月 | 0 | 315,048 | -315,048 |
最近36个月 | 0 | 317,584 | -317,584 |
Adaptimmune Therapeutics PLC 内部交易
Adaptimmune Therapeutics PLC 最新内部交易
Bertrand William C Jr | COO | 2024-01-17 | 卖出 | 23,589 | 20,201 |
$0.7
|
+53.57%
|
John Lunger | Chief Patient Supply Officer | 2024-01-17 | 卖出 | 22,795 | 19,015 |
$0.7
|
+53.57%
|
Elliot Norry | Chief Medical Officer | 2024-01-17 | 卖出 | 20,563 | 19,257 |
$0.69
|
+55.80%
|
Adrian Rawcliffe | CEO | 2024-01-17 | 卖出 | 39,384 | 44,848 |
$0.7
|
+53.57%
|
John Lunger | Chief Patient Supply Officer | 2024-01-12 | 卖出 | 9,229 | 7,874 |
$0.85
|
+26.47%
|
Adrian Rawcliffe | CEO | 2024-01-12 | 卖出 | 29,202 | 26,388 |
$0.85
|
+26.47%
|
Bertrand William C Jr | COO | 2024-01-12 | 卖出 | 9,229 | 7,874 |
$0.85
|
+26.47%
|
Elliot Norry | Chief Medical Officer | 2024-01-12 | 卖出 | 11,808 | 11,841 |
$0.85
|
+26.47%
|
Adrian Rawcliffe | CEO | 2023-09-01 | 卖出 | 2,403 | 3,449 |
$0.78
|
+37.82%
|
John Lunger | Chief Patient Supply Officer | 2023-08-01 | 卖出 | 3,096 | 4,718 |
$0.91
|
+18.13%
|